Clinton Outlines Two New Cancer Initiatives

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 11
Volume 7
Issue 11

WASHINGTON--On the day of The March, President Clinton announced two new cancer initiatives and issued a challenge to cancer researchers that sounded more like a "Mission Impossible" assignment.

WASHINGTON--On the day of The March, President Clinton announced two new cancer initiatives and issued a challenge to cancer researchers that sounded more like a "Mission Impossible" assignment.

The President said that all federal cancer research programs will "by next year, fully integrate patients and advocates into the process of setting research priorities."

He also directed the National Cancer Institute to speed development of a national clinical trials program and to make it "a simple, accessible resource for health care providers and patients across our nation."

Mr. Clinton then challenged scientists "to develop, by the year 2000, new diagnostic techniques for every major kind of cancer so we catch it at its earliest and often most treatable stage."

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content